0001179110-16-017785.txt : 20160115
0001179110-16-017785.hdr.sgml : 20160115
20160115201110
ACCESSION NUMBER: 0001179110-16-017785
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160115
FILED AS OF DATE: 20160115
DATE AS OF CHANGE: 20160115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rothera Mark
CENTRAL INDEX KEY: 0001550424
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 161346741
MAIL ADDRESS:
STREET 1: C/O AEGERION PHARMACEUTICALS, INC.
STREET 2: 101 MAIN STREET, SUITE 1850
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2016-01-15
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001550424
Rothera Mark
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
Chief Commercial Officer
Common Stock
2016-01-15
4
M
0
3125
10.85
A
3125
D
Common Stock
9216
I
By Trust
Stock Option (Right To Buy)
10.85
2016-01-15
4
M
0
3125
0
D
2015-05-15
Common Stock
3125
84534
D
Stock Option (Right To Buy)
10.85
2023-05-15
Common Stock
8125
8125
D
Stock Option (Right To Buy)
27.05
2024-01-27
Common Stock
65000
65000
D
Stock Option (Right To Buy)
51
2025-01-01
Common Stock
69550
69550
D
Stock Option (Right To Buy)
30.86
2026-01-03
Common Stock
70000
70000
D
This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vested on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
Shares held by trust of which reporting person's spouse is a beneficiary.
/s/ Colleen Diver Johnson, attorney-in-fact
2016-01-15